In a significant advancement for prostate cancer care, researchers from the US, UK, and Switzerland have developed an artificial intelligence (AI) tool capable of predicting which men with high-risk, non-metastatic prostate cancer will benefit from t...
Markdown supported · ⌘↵ to post
No responses yet.